Investments
39Portfolio Exits
7Funds
1Partners & Customers
1
Want to inform investors similar to Ohio Innovation Fund about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Ohio Innovation Fund News
Apr 18, 2023
News provided by Share this article Midwest emerging growth companies set to present in-person in Ann Arbor ANN ARBOR, Mich., April 18, 2023 /PRNewswire/ -- Organizers of the Midwest Growth Capital Symposium (MGCS) announced today that Louis Cannon, MD, Founder and Senior Managing Director of Biostar Capital, and Dug Song, Co-Founder and President of the Song Foundation, will keynote the 2023 program. More than 300 entrepreneurs, researchers, investment professionals, and business executives are expected to attend the two-day venture investment conference. For 2023, MGCS will include panel discussions on venture capital, technology, healthcare, acquisition, and more led by industry experts, as well as presentations from high-growth Midwest ventures. Featured panelists for MGCS include: Pete Wilkins, Managing Director for Hyde Park Angels Jeff Sloan, Angel Investor, CEO of Startup Nation, CEO of Aria Ventures Alan Davis, Managing Director of Biostar Capital Jake Cohen, Partner with Detroit Venture Partners and Co-founder of Signal Advisors Chin Weerapuli, NIL Advocate for University of Michigan Athletes Michael Spath, Client Executive for Kapnick Insurance, Executive Director for A2 New Tech Ashley Williams, Founder & CEO of RIZZARR Bill Baumel, Managing Director of the Ohio Innovation Fund Dr. Tom Shehab, Managing Partner of Arboretum Ventures Jing Liu, Executive Director of the Michigan Institute for Data Science The growing ventures featured in the MGCS showcase span the life sciences, medical devices, agriculture/food, and tech industries. All featured companies will be seeking seed, Series A, or Series B funding. In addition to their on-demand virtual pitches, presenting companies will be in attendance to connect with potential investors. "The goal from the onset of the Midwest Growth Capital Symposium is to bring together private growth companies and venture capital and private equity investment firms from all parts of the country," said David Brophy, founder of the Midwest Growth Capital Symposium and University of Michigan professor emeritus. "Since the beginning of the pandemic, VCs and other investors have been searching to make good deals with cutting-edge companies. The Symposium connects these investors with growing ventures that have an early track record of success – many that lack visibility as they are based in the Midwest." The 2023 Symposium will return in person to Ann Arbor May 23 & 24. The Symposium will be held at the Ross School of Business at the University of Michigan. For more information on applying, attending, or sponsoring the symposium, please visit www.midwestgcs.com or email Hannah Burke [email protected] . About the Midwest Growth Capital Symposium The Midwest Growth Capital Symposium (MGCS) is the original university-based venture investment fair. First held in 1980, this decades-old event is the largest Midwest venture fair of its kind that brings together venture capital investors, angel investors, high-growth companies, university tech transfer officers and research faculty. The Symposium is presented by the Zell Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business. SOURCE Midwest Growth Capital Symposium ×
Ohio Innovation Fund Investments
39 Investments
Ohio Innovation Fund has made 39 investments. Their latest investment was in Invirsa as part of their Series A on December 12, 2022.

Ohio Innovation Fund Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
12/30/2022 | Series A | Invirsa | $5.98M | Yes | 1 | |
10/6/2022 | Series C | Genetesis | $17.5M | No | Alumni Ventures, Cercano Management, CincyTech, JobsOhio, Mithril Capital Management, Ohio Innovation Fund, and Undisclosed Investors | 10 |
1/27/2022 | Series C | Enable Injections | $215M | No | 10 | |
9/24/2021 | Series C | |||||
11/12/2020 | Series B |
Date | 12/30/2022 | 10/6/2022 | 1/27/2022 | 9/24/2021 | 11/12/2020 |
---|---|---|---|---|---|
Round | Series A | Series C | Series C | Series C | Series B |
Company | Invirsa | Genetesis | Enable Injections | ||
Amount | $5.98M | $17.5M | $215M | ||
New? | Yes | No | No | ||
Co-Investors | Alumni Ventures, Cercano Management, CincyTech, JobsOhio, Mithril Capital Management, Ohio Innovation Fund, and Undisclosed Investors | ||||
Sources | 1 | 10 | 10 |
Ohio Innovation Fund Portfolio Exits
7 Portfolio Exits
Ohio Innovation Fund has 7 portfolio exits. Their latest portfolio exit was Complion on December 07, 2022.
Ohio Innovation Fund Fund History
1 Fund History
Ohio Innovation Fund has 1 fund, including Ohio Innovation Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
5/10/2017 | Ohio Innovation Fund | $5M | 1 |
Closing Date | 5/10/2017 |
---|---|
Fund | Ohio Innovation Fund |
Fund Type | |
Status | |
Amount | $5M |
Sources | 1 |
Ohio Innovation Fund Partners & Customers
1 Partners and customers
Ohio Innovation Fund has 1 strategic partners and customers. Ohio Innovation Fund recently partnered with ConnXus on August 8, 2018.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
8/16/2018 | Partner | United States | `` Ohio Innovation Fund 's partners GET software , '' said Rod Robinson , Founder and CEO of ConnXus , Inc. . | 1 |
Date | 8/16/2018 |
---|---|
Type | Partner |
Business Partner | |
Country | United States |
News Snippet | `` Ohio Innovation Fund 's partners GET software , '' said Rod Robinson , Founder and CEO of ConnXus , Inc. . |
Sources | 1 |
Ohio Innovation Fund Team
1 Team Member
Ohio Innovation Fund has 1 team member, including current Managing Director, Bill Baumel.
Name | Work History | Title | Status |
---|---|---|---|
Bill Baumel | RWI Ventures, Coral Group, Procter & Gamble, and Deloitte | Managing Director | Current |
Name | Bill Baumel |
---|---|
Work History | RWI Ventures, Coral Group, Procter & Gamble, and Deloitte |
Title | Managing Director |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.